Results for tag: "Behcet Disease Drug"

Behcet Disease is a rare, chronic, inflammatory disorder that affects the blood vessels throughout the body. Hematological drugs are used to treat the symptoms of Behcet Disease, such as inflammation, pain, and ulcers. These drugs are typically immunosuppressants, corticosteroids, and biologics. Immunosuppressants are used to reduce inflammation and suppress the immune system, while corticosteroids are used to reduce inflammation and pain. Biologics are used to target specific parts of the immune system and reduce inflammation. The Behcet Disease Drug market is a small but growing market, with a focus on developing treatments that are effective and safe. Companies in the market are researching and developing new drugs to treat the symptoms of Behcet Disease, as well as exploring new ways to diagnose and monitor the disease. Companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more